Titan Medical Completes Build of Its Next-Generation Single-Port Robotic Surgical System
January 03 2019 - 8:36AM
Business Wire
Product enhancements video available on
corporate website
Titan Medical Inc. (TSX: TMD) (Nasdaq: TMDI) (“Titan” or the
“Company”), a medical device company focused on the design and
development of a robotic surgical system for application in
minimally invasive surgery (“MIS”), announces that it has completed
the system engineering confidence build for all components of its
single-port robotic surgery system. This accomplishment highlights
the completion of a new camera system along with the design
enhancements of both the surgeon workstation and the patient cart,
the two primary components of the system. The engineering
confidence build reflects all significant improvements inspired by
the Company’s preclinical experience. A video highlighting the
system enhancements is available on the Company’s website here.
“I extend congratulations to Dr. Perry Genova, our Senior Vice
President of Research and Development, and our engineering team for
achieving this significant development milestone on an aggressive
schedule during the fourth quarter of 2018,” said David McNally,
president and chief executive officer of Titan Medical. “We are
proud of their accomplishments and are thrilled with our
substantial progress in 2018, and note that timely completion of
this build is a critical step in preparation to file for regulatory
clearances in the U.S. and the European Union. We are also grateful
to the visionary surgeons who performed 45 preclinical studies with
our earlier SPORT system prototype, including 14 different
procedures within four surgical disciplines, providing key input to
our design team. As a result, our single-port robotic system now
incorporates multiple important and patent-pending enhancements
specifically intended to improve surgical performance and ease of
use, which will better position us in the rapidly-expanding
surgical robotics market.”
Mr. McNally added, “We welcome viewers to our website where we
have posted video of the SPORT system enhancements, which include a
completely redesigned unique dual-camera system with a 3D
high-definition steerable endoscopic camera for use during surgery,
as well as a 2D high-definition wide-angle camera integrated into
the camera insertion tube for visualization of instrument
insertions, which also serves as a backup camera for safety. The
engineering team has also designed a more compact and significantly
lighter patient cart, with a reduced footprint designed to optimize
portability, minimize set-up time and facilitate unencumbered
assistance of surgical staff at the patient bedside. Further, we
have improved the surgeon interface at the workstation with a more
comfortable handle design, a new 4K monitor and upgraded haptic
feedback with image overlays to assist the surgeon with the
positioning of the instruments for optimal performance. We are
excited to move into 2019 with this next-generation single-port
robotic surgical system, with a focus on meeting our regulatory
milestones.”
About Titan Medical Inc.
Titan Medical Inc. is focused on computer-assisted robotic
surgical technologies for application in minimally invasive
surgery. The Company is developing the SPORT Surgical System, a
single-port robotic surgical system comprised of a
surgeon-controlled patient cart that includes a 3D high-definition
vision system and multi-articulating instruments for performing MIS
procedures, and a surgeon workstation that provides an advanced
ergonomic interface to the patient cart and a 3D endoscopic view
inside the patient’s body. Titan intends to initially pursue
focused surgical indications for the SPORT Surgical System, which
may include one or more of gynecologic, urologic, colorectal or
general abdominal procedures.
For more information, please visit the Company’s website at
www.titanmedicalinc.com.
Forward-Looking Statements
This news release contains “forward-looking statements” which
reflect the current expectations of management of the Company’s
future growth, results of operations, performance and business
prospects and opportunities. Wherever possible, words such as
“may”, “would”, “could”, “will”, “anticipate”, “believe”, “plan”,
“expect”, “intend”, “estimate”, “potential for” and similar
expressions have been used to identify these forward-looking
statements. These statements reflect management’s current beliefs
with respect to future events and are based on information
currently available to management. Forward-looking statements
involve significant risks, uncertainties and assumptions. Many
factors could cause the Company’s actual results, performance or
achievements to be materially different from any future results,
performance or achievements that may be expressed or implied by
such forward-looking statements, including, without limitation,
those listed in the “Risk Factors” section of the Company’s Annual
Information Form dated March 31, 2018 (which may be viewed at
www.sedar.com). Should one or more of these risks or uncertainties
materialize, or should assumptions underlying the forward-looking
statements prove incorrect, actual results, performance or
achievements may vary materially from those expressed or implied by
the forward-looking statements contained in this news release.
These factors should be considered carefully, and prospective
investors should not place undue reliance on the forward-looking
statements. Although the forward-looking statements contained in
the news release are based upon what management currently believes
to be reasonable assumptions, the Company cannot assure prospective
investors that actual results, performance or achievements will be
consistent with these forward-looking statements.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190103005374/en/
LHA Investor RelationsKim Sutton Golodetz(212)
838-3777kgolodetz@lhai.comorBruce Voss(310)
691-7100bvoss@lhai.com
Titan Medical (NASDAQ:TMDI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Titan Medical (NASDAQ:TMDI)
Historical Stock Chart
From Apr 2023 to Apr 2024